Two Sigma Advisers’s Evolv Technologies EVLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,740,800
Closed -$19.6M 715
2025
Q4
$19.6M Buy
2,740,800
+689,800
+34% +$4.9M 0.04% 363
2025
Q3
$15.5M Buy
2,051,000
+892,200
+77% +$6.51M 0.03% 384
2025
Q2
$7.23M Buy
+1,158,800
New +$5.36M 0.01% 623
2024
Q2
Sell
-198,400
Closed -$883K 2512
2024
Q1
$883K Sell
198,400
-191,800
-49% -$829K ﹤0.01% 1641
2023
Q4
$1.84M Sell
390,200
-31,400
-7% -$134K ﹤0.01% 1330
2023
Q3
$2.05M Buy
421,600
+356,500
+548% +$2.2M 0.01% 1189
2023
Q2
$391K Buy
+65,100
New +$308K ﹤0.01% 1896

Other funds holding EVLV

Two Sigma Advisers's EVLV Position: Q1 2026 in Review

Two Sigma Advisers sold out of Evolv Technologies (EVLV) in Q1 2026, closing a stake of 2,740,800 shares — an estimated $19.6M sold.

Two Sigma Advisers first reported a position in EVLV in Q2 2023 and held it in 7 quarters. The position peaked at $19.6M in Q4 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • Two Sigma Advisers reported no remaining Evolv Technologies position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 2,740,800 Evolv Technologies shares in Q1 2026, an estimated $19.6M.
  • Two Sigma Advisers first reported a position in Evolv Technologies in Q2 2023 and held it in 7 quarters.
  • Two Sigma Advisers's Evolv Technologies position peaked at $19.6M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.